Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cerebral Adrenoleukodystrophy
- High Risk Hematologic Disorders
- Inherited Metabolic Disorders
- Sickle Cell Disease
- ? Thalassemia
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 25 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03367546
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Christen L Ebens, MD, MPH University of Minnesota - Pediatrics Blood and Marrow Transplant
Get Well Soon